President Donald Trump's plan to battle the opioid crisis includes a fresh public-awareness campaign about drug abuse, a research-and-development partnership between the National Institutes of Health and pharmaceutical companies into opioid prescription alternatives, tougher sentences for fentanyl traffickers, and screening of all prison inmates for opioid addiction.
from Kaiser Health News http://ift.tt/2FK9XPK
March 19, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
State Highlights: Advocates Call On New York Senate To Ban Conversion Therapy; Some Blue Cross Patients Face Paying 100% Of ER Visits In TexasMedia outlets report on news from New York, Texas, Ohio, Missouri, Illinois, Arizona, Louisiana and Pennsylvania. from Kaiser Health News https://ift.tt/2vO9ac3 … Read More
As Minibrain Research Continues To Progress, Scientists Begin To Wade Through Ethical ComplexitiesMinibrains hold tremendous potential for unraveling the mysteries around neurological diseases, but scientists worry about creating a sentient entity in the lab. In other public health news: tuberculosis; medical research; me… Read More
E. Coli Outbreak Continues To Grow While Source Still Remains UnknownThe CDC and the FDA say the growing region in Yuma, Ariz. is the source, but no farm has been identified. from Kaiser Health News https://ift.tt/2r1gsUd … Read More
Frustrated By Lack Of Research On Gun Violence, Governors Plan To ‘Take Matters Into Our Own Hands’Seven governors announce that their states will form an “unprecedented” consortium to tap into resources at universities and state agencies to help build up research on gun violence. from Kaiser Health News https://ift.tt/2r… Read More
Should Doctors Offer Immunotherapy To Terminal Cancer Patients? Some Are Rolling The DiceThe chance immunotherapy will help some patients is small — but not zero. “Under rules of desperation oncology, you engage in a different kind of oncology than the rational guideline thought,” says Dr. Oliver Sartor. Other do… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment